<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97507">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01977157</url>
  </required_header>
  <id_info>
    <org_study_id>11-189</org_study_id>
    <nct_id>NCT01977157</nct_id>
  </id_info>
  <brief_title>Alcohol Detection Via Bioimpedance Mesurements</brief_title>
  <acronym>AlkBIS</acronym>
  <official_title>Alcohol Detection Via Bioimpedance Mesurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examination if the bioimpendanz measurement can be used for the determination of the alcohol
      content in human blood.

      Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer
      and one blood test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol
      content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo).

      This technology is non-invasive an can be measured by using conductive electrodes,
      capacitive electrodes or inductive measurement systems.

      The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK
      III, Dräger, Lübeck, Germany).

      Furthermore one blood sample will be taken and analyzed with the ADH method as the current
      gold standard at the end of the trail.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Bioimpedance measurements</measure>
    <time_frame>4 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation if the bioimpedance measurements can be used to verify and quantify the alcohol content in human blood. Bioimpedance measurements will be conducted with the BIS device (SFB7, ImpediMed)  covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo,medis) operating at. The whole-body and hand-to-hand bioimpedance will be analyzed. Extracellular resistance (Re), intracellular resistance (Ri) and capacitive effects (Cm) are calculated by using the Cole model Grimnes (2000).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>bioimpedance measurements while trinking alcohol</arm_group_label>
    <description>Bioimpedance spectroscopy (BIS) measurements on 12 healthy subjects were performed while they were drinking alkohol until reaching a BAC of 0.8 ‰.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bioimpedance mesurements</intervention_name>
    <description>Bioimpedance measurements were conducted with a BIS device (SFB7, ImpediMed, Pinkeba, Australia) covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo, medis, Ilmenau, Germany)</description>
    <arm_group_label>bioimpedance measurements while trinking alcohol</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy male subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male subjects

          -  able to give informed consent

          -  Inconspicuous laboratory and drug screening

        Exclusion Criteria:

          -  electrophobica

          -  alcoholphobica, -allergy

          -  metallic ans / or electric implants

          -  underage persons

          -  interactively medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Czaplik, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology ,Chair for Medical Information Technology Helmholtz Institute for Biomedical Engineering RWTH Aachen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology, University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine-Westphalia</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 30, 2013</lastchanged_date>
  <firstreceived_date>October 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Impedance cardiography</keyword>
  <keyword>bioimpedance</keyword>
  <keyword>spectroscopy</keyword>
  <keyword>extracellular resistance</keyword>
  <keyword>body composition</keyword>
  <keyword>hemodynamics</keyword>
  <keyword>alcohol</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
